In the Chinese cohort of 627 patients with IIM, a statistically significant association of anti-TIF1-γ, anti-NXP2 and anti-SAE1 antibodies with a high risk of cancer were confirmed [49]. This evidence concerns the gene TRIM33 and cancer.